Skip to main content

Table 3 Results (multiple detections not included) of multiplex real-time polymerase chain reaction assays of all included patients in order of frequency and by randomisation group (rapid vs. delayed result group)

From: Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial

Detected pathogens All patients, n(%) Rapid result group, n(%) Delayed result group, n(%)
Influenza A virus 56 (13.8) 31 (15.3) 25 (12.3)
Rhinovirus 40 (9.9) 24 (11.9) 16 (7.8)
Coronavirus (all subtypes) 29 (7.1) 11 (5.4) 18 (8.8)
   Coronavirus OC43 16 (3.9) 4 (2.0) 12 (5.9)
   Coronavirus NL63 11 (2.7) 5 (2.5) 6 (2.9)
   Coronavirus 229E 2 (0.5) 2 (1.0) -
Respiratory syncytial virus 18 (4.4) 6 (3.0) 12 (5.9)
Influenza B virus 14 (3.4) 7 (3.5) 7 (3.4)
Metapneumovirus 14 (3.4) 6 (3.0) 8 (3.9)
Parainfluenzavirus types 1 through 3 7 (1.7) 4 (2.0) 3 (1.5)
Mycoplasma pneumoniae 7 (1.7) 5 (2.5) 2 (1.0)
Adenovirus 4 (1.0) 2 (1.0) 2 (1.0)
Enterovirus 1 (0.2) - 1 (0.5)
Chlamydophila pneumoniae 1 (0.2) 1 (0.5) -
No pathogen found 215 (53.0) 105 (52.0) 110 (54)
Total, N (%) 406 (100) 202 (100) 204 (100)